Safety of intravenous recombinant tissue plasminogen activator in recent trauma

被引：0
|
作者：
Zabeen Mahuwala
Archana Hinduja
机构：
[1] University of Arkansas for Medical Sciences,Department of Neurology
来源：
Acta Neurologica Belgica | 2014年 / 114卷
关键词：
Tissue plasminogen activator; Intravenous; Trauma; Pelvic fracture;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：163 / 164
页数：1
相关论文
共 50 条
  • [1] Safety of intravenous recombinant tissue plasminogen activator in recent trauma
    Mahuwala, Zabeen
    Hinduja, Archana
    [J]. ACTA NEUROLOGICA BELGICA, 2014, 114 (02) : 163 - 164
  • [2] Defining Intravenous Recombinant Tissue Plasminogen Activator Failure
    Guerrero, Waldo R.
    Grotta, James C.
    [J]. STROKE, 2013, 44 (03) : 819 - 821
  • [3] Intravenous recombinant tissue plasminogen activator for acute ischemic stroke: a feasibility and safety study
    Sadeghi-Hokmabadi, Elyar
    Farhoudi, Mehdi
    Taheraghdam, Aliakbar
    Hashemilar, Mazyar
    Savadi-Osguei, Daryous
    Rikhtegar, Reza
    Mehrvar, Kaveh
    Sharifipour, Ehsan
    Youhanaee, Parisa
    Mirnour, Reshad
    [J]. INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2016, 9 : 361 - 367
  • [4] Intravenous Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Patients With Recent Myocardial Infarction.
    Inohara, Taku
    Liang, Li
    Kosinski, Andrzej
    Smith, Eric E.
    Schwamm, Lee H.
    Hernandez, Adrian F.
    Bhatt, Deepak L.
    Fonarow, Gregg C.
    Peterson, Eric D.
    Xian, Ying
    [J]. STROKE, 2019, 50
  • [5] Intravenous Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Patients With Gastrointestinal Malignancy or Recent Bleeding
    Inohara, Taku
    Liang Li
    Kosinski, Andrzej
    Smith, Eric E.
    Schwamm, Lee H.
    Hernandez, Adrian F.
    Bhatt, Deepak L.
    Fonarow, Gregg C.
    Peterson, Eric D.
    Xian Ying
    [J]. CIRCULATION, 2018, 138
  • [6] Safety and Effectiveness of Intravenous Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke Patients on Aspirin and Clopidogrel
    Qureshi, Mushtaq H.
    Khan, Shayaan M.
    Jahangir, Nauman
    Malik, Ahmed A.
    Freese, Melissa
    Thompson, Michelle
    Khan, Asif A.
    Suri, M. Fareed K.
    Qureshi, Adnan I.
    [J]. STROKE, 2015, 46
  • [7] Use of intravenous recombinant tissue plasminogen activator in patients outside the defined criteria: safety and feasibility issues
    Matz, Karl
    Brainin, Michael
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2013, 13 (02) : 177 - 185
  • [8] Intravenous thrombolysis with recombinant tissue plasminogen activator in vascular warning syndromes
    Gonzalez Hernandez, A.
    Fabre Pi, O.
    Cabrera Naranjo, F.
    Lopez Veloso, A. C.
    [J]. NEUROLOGIA, 2014, 29 (06): : 334 - 338
  • [9] Update on Intravenous Recombinant Tissue Plasminogen Activator for Acute Ischemic Stroke
    Fugate, Jennifer E.
    Rabinstein, Alejandro A.
    [J]. MAYO CLINIC PROCEEDINGS, 2014, 89 (07) : 960 - 972
  • [10] Efficacy and safety of intravenous recombinant tissue plasminogen activator in mild ischaemic stroke: a meta-analysis
    You, Shoujiang
    Saxena, Anubhav
    Wang, Xia
    Tan, WeeYong
    Han, Qiao
    Cao, Yongjun
    Liu, Chun-Feng
    [J]. STROKE AND VASCULAR NEUROLOGY, 2018, 3 (01) : 22 - 27
12345